From the *Institut Curie, Hôpital René Huguenin, Saint-Cloud, France; and †Institut Gustave Roussy, Villejuif, France.
Anesth Analg. 2017 Oct;125(4):1342-1347. doi: 10.1213/ANE.0000000000002003.
Although thoracic paravertebral block (TPVB) is recommended in major breast surgery, there is no gold standard to assess the success of TPVB. Pupillary dilation reflex (PDR) is the variation of the pupillary diameter after a noxious stimulus. The objective was to evaluate the feasibility of recording the PDR to assess analgesia in an anesthetized thoracic dermatome after TPVB.
This prospective, observational, single-center study included 32 patients requiring breast surgery under general anesthesia and TPVB. TPVB was performed before surgery under ultrasound guidance with 20 mL of 0.75% ropivacaine. At the end of the surgery, remifentanil was stopped and the PDR was recorded after a 5-second tetanic stimulation (60 mA, 100 Hz) applied to the anterior chest wall. The PDR was defined as the maximal increase in pupil diameter after a standardized noxious stimulus, expressed as a percentage of the initial pupil diameter. The PDR was recorded twice in the same eye for each patient after a stimulus on both the TPVB and the control sides. Postoperative pain scores were recorded in a postanesthesia care unit. The primary outcome was the difference between the PDR on the TPVB and the control sides.
The median (interquartile range) PDR was 9% (4%-13%) on the TPVB side and 41% (27%-66%) on the control side. There was a significant difference in the PDR between the TPVB and the control sides with a Hodges-Lehmann estimate of absolute difference of 37% points (95% confidence interval, 25-52, P < .001). Median postoperative pain scores (interquartile range) in the postanesthesia care unit were 1 (0-3) at rest and 1 (0-3) during mobilization, respectively. There was a linear correlation between maximal postoperative pain scores and the PDR on the TPVB side with a Pearson's correlation coefficient r = 0.40 (95% confidence interval, 0.06-0.66, P = .02). No correlation was found between the number of blocked dermatomes and maximal postoperative pain scores (P = .06) or between the number of blocked dermatomes and the PDR on the TPVB side (P = .15).
This proof-of-concept trial suggests that the effect of TPVB could be monitored by measuring the PDR after anterior chest wall stimulation in the dermatome of interest.
尽管胸段椎旁阻滞(TPVB)在大型乳房手术中被推荐使用,但目前仍没有评估 TPVB 成功的金标准。瞳孔扩张反射(PDR)是有害刺激后瞳孔直径的变化。本研究旨在评估记录 PDR 以评估 TPVB 后麻醉胸部皮区镇痛的可行性。
这是一项前瞻性、观察性、单中心研究,纳入了 32 例在全身麻醉和 TPVB 下接受乳房手术的患者。TPVB 在超声引导下进行,在前胸壁上注入 20ml 0.75%罗哌卡因。手术结束时,停止使用瑞芬太尼,并在对前胸壁施加 5 秒强直刺激(60mA,100Hz)后记录 PDR。PDR 定义为标准化有害刺激后瞳孔直径的最大增加,以初始瞳孔直径的百分比表示。每个患者的同一只眼在 TPVB 侧和对照侧均接受刺激后,记录 PDR 两次。术后疼痛评分在麻醉后恢复室(PACU)中记录。主要结局是 TPVB 侧和对照侧的 PDR 之间的差异。
TPVB 侧的 PDR 中位数(四分位距)为 9%(4%-13%),对照侧为 41%(27%-66%)。TPVB 侧和对照侧的 PDR 之间存在显著差异,Hodges-Lehmann 估计绝对差值为 37%(95%置信区间,25-52,P<0.001)。PACU 中术后静息时的中位数疼痛评分(四分位距)分别为 1(0-3)和 1(0-3),运动时分别为 1(0-3)和 1(0-3)。最大术后疼痛评分与 TPVB 侧的 PDR 之间存在线性相关性,Pearson 相关系数 r = 0.40(95%置信区间,0.06-0.66,P = 0.02)。但未发现阻滞皮区数量与最大术后疼痛评分之间存在相关性(P = 0.06),也未发现阻滞皮区数量与 TPVB 侧的 PDR 之间存在相关性(P = 0.15)。
这项概念验证试验表明,通过在前胸壁刺激感兴趣的皮区后测量 PDR,可以监测 TPVB 的效果。